Inhaled fungal pathogens often generate granuloma-contained latent infections that can reactivate to cause invasive disease. However, why protective pathways fail to achieve sterilizing immunity in this setting is unclear. Here, we identify type 2 inflammation as a major arm of immunosuppression during latent, granulomatous fungal infection. Using reporter mice, we found that TH2 cells were the dominant source of type 2 cytokines and deletion of IL-4/IL-13, Stat6, or TH2 cells drove fungal clearance. Type 2 signaling acted on monocyte-derived myeloid cells that formed an ARG1+ ring around the granuloma core. STAT6 was required cell intrinsically in this compartment, and its loss reduced lung burden. Contrary to an intracellular-niche model, we found that Cryptococcus was predominantly extracellular in vivo. STAT6 deficiency did not enhance macrophage intracellular killing, but instead antagonized IFNγ-dependent protection against extracellular yeast. These findings identify a spatially organized TH2-STAT6 checkpoint that limits IFNγ-mediated extracellular killing and maintains cryptococcal latency.
Alternatively activated monocyte-derived myeloid cells promote extracellular pathogen persistence in pulmonary fungal granulomas
Y. Zheng and M. Jean Pierre contributed equally to this paper.
Disclosures: The authors declare no competing interests exist.
C.U. Onyishi’s current affiliation is Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA.
Eric V. Dang’s current affiliation is Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA.
- Award Id(s): ZIA-AI001364,1ZIAAI001388-01
- Award Id(s): R01AI176922,F31AI181528
Yufan Zheng, Makheni Jean Pierre, Eduard Ansaldo, Hannah E. Dobson, Olena Kamenyeva, Chinaemerem U. Onyishi, Sarah Douglas, Christopher Febres Aldana, Pinar Engin Zerk, Irini Sereti, Jovany J. Betancourt, Kirsten Nielsen, Erin McCaffery, Eric V. Dang; Alternatively activated monocyte-derived myeloid cells promote extracellular pathogen persistence in pulmonary fungal granulomas. J Exp Med 4 May 2026; 223 (5): e20260208. doi: https://doi.org/10.1084/jem.20260208
Download citation file:
Sign in
Email alerts
Advertisement
